Ads
related to: pfizer- Chipmaker Set to Soar Now
Best 2024 Semiconductor Stock?
One Chipmaker Worth Buying Now
- 3 Hottest Software Stocks
Top plays from a surging industry.
Free report names must-buy stocks.
- Free: Invest Like Buffett
5 "Buffett stocks" to buy right now
New report names 5 wealth-builders
- Top EV Stocks to Buy Now
5 EV Picks Better than Tesla
5 Stocks with Big Profit Potential
- 2024's Gold Rush is Here
Gold Prices Could Reach New Highs
See This Year's Top Gold Plays Free
- Anti-Gold Investor Guide
Investments to buy instead of gold
Free guide to protect your wealth
- Chipmaker Set to Soar Now
Search results
Pfizer drug extends life for patients with rare lung cancer usually seen in nonsmokers
NBC Universal via AOL· 7 days agoPfizer’s lung cancer drug Lorbrena can extend life for patients with a rare form of the disease for...
Pfizer (NYSE:PFE) Trading 0.3% Higher
ETF DAILY NEWS· 21 hours agoPfizer Inc. (NYSE:PFE – Get Free Report) traded up 0.3% during mid-day trading on Tuesday . The company traded as high as $29.73 and last traded at $29.41. 9,834,266 shares ...
How To Earn $500 A Month From Pfizer Stock
Benzinga via AOL· 7 days agoShares of Pfizer Inc. (NYSE:PFE) closed higher during Thursday's session, with the company's stock adding around 10% over the past month. Pfizer recently...
Is Pfizer Inc. (NYSE:PFE) the Best Gene Therapy Stock to Buy Now?
Insider Monkey via Yahoo Finance· 3 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
Why Things Could Get Worse for Pfizer Stock Before They Get Better
The Motley Fool via AOL· 2 days agoA few years ago, in the race to launch a COVID-19 vaccine, Pfizer (NYSE: PFE) stock was a hot buy...
Pfizer drug extends life for people with rare form of lung cancer
AFP via Yahoo News· 7 days agoA Pfizer lung cancer drug has been shown to greatly reduce tumor progression and improve survival...
Is Pfizer the Best Dividend Stock for You?
Motley Fool via Yahoo Finance· 6 days agoThe pandemic-influenced revenue gusher from which pharmaceutical giant Pfizer (NYSE: PFE) benefitted a few years ago has trickled down to a small stream....
Relay in clinical trial collaboration with Pfizer for breast cancer combo treatment
Seeking Alpha· 1 day agoRelay Therapeutics collaborates with Pfizer to investigate combination therapy for breast cancer using RLY-2608 and atirmociclib. Read more here.
Pfizer: New Cancer Drugs Could Breathe New Life Into Struggling Pharma Behemoth
Investing.com· 3 days agoPharmaceutical stocks, once pandemic favorites, have faced significant corrections. Despite broader...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer | The Motley...
The Motley Fool· 3 days agoPfizer (PFE 0.61%) investors have been through a lot of ups and downs over the past few years....